Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity.
作者信息
Mann J S, Howarth P H, Holgate S T
出版信息
Br Med J (Clin Res Ed). 1984 Aug 25;289(6443):469. doi: 10.1136/bmj.289.6443.469.
Abstract
摘要
相似文献
1
Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity.异丙托溴铵诱发哮喘患者支气管收缩：与低渗性的关系
Br Med J (Clin Res Ed). 1984 Aug 25;289(6443):469. doi: 10.1136/bmj.289.6443.469.
2
Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity.异丙托溴铵在哮喘中诱发的支气管收缩：与低渗性的关系。
Br Med J (Clin Res Ed). 1984 Sep 29;289(6448):833. doi: 10.1136/bmj.289.6448.833-a.
3
Bronchoconstriction in response to ipratropium bromide.对异丙托溴铵的支气管收缩反应。
Br Med J (Clin Res Ed). 1983 Apr 23;286(6374):1318. doi: 10.1136/bmj.286.6374.1318.
4
Bronchoconstriction induced by nebulised ipratropium bromide: relation to the bromide ion.雾化吸入异丙托溴铵引起的支气管收缩：与溴离子的关系。
Br Med J (Clin Res Ed). 1986 Dec 13;293(6561):1538-9. doi: 10.1136/bmj.293.6561.1538.
5
Bronchoconstriction in response to ipratropium bromide.对异丙托溴铵的支气管收缩反应。
Br Med J (Clin Res Ed). 1983 Jun 4;286(6380):1825-6. doi: 10.1136/bmj.286.6380.1825-b.
6
Airways responses to ipratropium bromide do not vary with time in asthmatic subjects. Studies of interindividual and intraindividual variation of bronchodilatation and protection against histamine-induced bronchoconstriction.哮喘患者气道对异丙托溴铵的反应不会随时间而变化。关于支气管扩张以及预防组胺诱导的支气管收缩的个体间和个体内变异性研究。
Chest. 1990 Jan;97(1):46-51. doi: 10.1378/chest.97.1.46.
7
Maximal expiratory flows and forced vital capacity in normal, asthmatic and bronchitic subjects after salbutamol and ipratropium bromide.沙丁胺醇和异丙托溴铵对正常、哮喘和支气管炎患者最大呼气流量及用力肺活量的影响
Respiration. 1982;43(4):304-16. doi: 10.1159/000194499.
8
Adverse reaction to ipratropium bromide.异丙托溴铵的不良反应。
Br Med J (Clin Res Ed). 1982 Nov 13;285(6352):1425-6. doi: 10.1136/bmj.285.6352.1425-d.
9
Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution.异丙托溴铵（爱全乐）雾化溶液中防腐剂的支气管收缩特性。
Br Med J (Clin Res Ed). 1987 May 9;294(6581):1197-8. doi: 10.1136/bmj.294.6581.1197-a.
10
A comparison of oxitropium bromide and ipratropium bromide in asthma.
Eur J Respir Dis. 1984 Feb;65(2):106-8.
引用本文的文献
1
G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.哮喘治疗中的 G 蛋白偶联受体：药理学和药物作用。
Pharmacol Rev. 2020 Jan;72(1):1-49. doi: 10.1124/pr.118.016899.
2
Safety Considerations with Dual Bronchodilator Therapy in COPD: An Update.慢性阻塞性肺疾病双重支气管扩张剂治疗的安全性考量：最新进展
Drug Saf. 2016 Jun;39(6):501-8. doi: 10.1007/s40264-016-0402-4.
3
Patients' practices and experiences of using nebuliser therapy in the management of COPD at home.患者在家中使用雾化器治疗 COPD 的实践和经验。
BMJ Open Respir Res. 2015 Feb 24;2(1):e000076. doi: 10.1136/bmjresp-2014-000076. eCollection 2015.
4
Differential pharmacology and clinical utility of emerging combination treatments in the management of COPD--role of umeclidinium/vilanterol.慢性阻塞性肺疾病管理中新型联合治疗的差异药理学及临床应用——乌美溴铵/维兰特罗的作用
Int J Chron Obstruct Pulmon Dis. 2014 Jun 27;9:687-95. doi: 10.2147/COPD.S47792. eCollection 2014.
5
Physicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions.丙酸氟替卡松雾化混悬液与异丙托溴铵及沙丁胺醇雾化溶液的物理化学相容性
Int J Chron Obstruct Pulmon Dis. 2007;2(4):599-607.
6
Anticholinergic agents for chronic asthma in adults.用于成人慢性哮喘的抗胆碱能药物。
Cochrane Database Syst Rev. 2004;2004(3):CD003269. doi: 10.1002/14651858.CD003269.pub2.
7
HRCT imaging of airway responsiveness: effects of anesthetics.气道反应性的高分辨率计算机断层扫描成像：麻醉剂的影响
J Clin Monit Comput. 2000;16(5-6):443-55. doi: 10.1023/a:1011496810978.
8
Nebulisers for asthma.用于哮喘的雾化器。
Thorax. 1997 Apr;52 Suppl 2(Suppl 2):S45-8. doi: 10.1136/thx.52.2008.s45.
9
Adverse drug events related to dosage forms and delivery systems.与剂型和给药系统相关的药物不良事件。
Drug Saf. 1996 Jan;14(1):39-67. doi: 10.2165/00002018-199614010-00005.
10
Adverse reactions to the non-drug constituents of nebuliser solutions.雾化器溶液中非药物成分的不良反应。
Br J Clin Pharmacol. 1988 Mar;25(3):283-7. doi: 10.1111/j.1365-2125.1988.tb03305.x.
本文引用的文献
1
Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline.对吸入超声雾化蒸馏水和盐水溶液的支气管高反应性。
Br Med J (Clin Res Ed). 1981 Nov 14;283(6302):1285-7. doi: 10.1136/bmj.283.6302.1285.
2
Bronchoconstriction in response to ipratropium bromide.对异丙托溴铵的支气管收缩反应。
Br Med J (Clin Res Ed). 1983 Jun 4;286(6380):1825-6. doi: 10.1136/bmj.286.6380.1825-b.
3
Bronchoconstriction in response to ipratropium bromide.对异丙托溴铵的支气管收缩反应。
Br Med J (Clin Res Ed). 1983 Apr 23;286(6374):1318. doi: 10.1136/bmj.286.6374.1318.
4
Adverse reaction to ipratropium bromide.异丙托溴铵的不良反应。
Br Med J (Clin Res Ed). 1982 Oct 2;285(6346):934-5. doi: 10.1136/bmj.285.6346.934.
5
The effects of ultrasonically-produced aerosols on airway resistance in man.超声产生的气雾剂对人体气道阻力的影响。
Anesthesiology. 1968 Nov-Dec;29(6):1099-106. doi: 10.1097/00000542-196811000-00004.
Zotero 插件